Publication | Closed Access

Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001

UrologyOncologyMedicinePharmacotherapyAnti-cancer AgentMtor Inhibitor Rad001Cancer TreatmentSimultaneous ApplicationPharmacologyProstatic DiseaseDrug DiscoveryProstate Cancer Growth